[Elevated D-dimer in patients with cardiovascular diseases free from thromboembolic complications: what is it

Insights

Elevated D-dimer levels in cardiovascular disease (CVD) patients without thromboembolic complications are predicted by female gender, age over 68, acute inflammation, pulmonary hypertension, and decompensated chronic cardiac insufficiency (CCI). These factors are key for risk assessment in CVD management.

Area of Science:

  • Cardiology
  • Hematology
  • Internal Medicine

Background:

  • Cardiovascular diseases (CVD) are a leading cause of morbidity and mortality worldwide.
  • D-dimer is a degradation product of cross-linked fibrin, often elevated in thrombotic disorders.
  • Understanding D-dimer elevation in CVD patients without overt thromboembolism is crucial for risk stratification.

Purpose of the Study:

  • To identify factors associated with elevated D-dimer levels in patients diagnosed with cardiovascular diseases (CVD).
  • To specifically investigate predictors in CVD patients without apparent thromboembolic complications.

Main Methods:

  • Retrospective analysis of 1,000 cardiovascular disease (CVD) patient case histories.
  • D-dimer levels measured using latex agglutination; normal upper limit set at 0.5 μg/ml.
  • Univariate and multivariate analyses performed on 867 patients without manifest thromboembolic complications.

Main Results:

  • 32% of CVD patients without apparent thromboembolic complications exhibited elevated D-dimer levels.
  • Univariate analysis identified 14 associated parameters (e.g., female gender, age >68, chronic cardiac insufficiency).
  • Multivariate analysis revealed independent predictors: female gender, age >68 years, acute inflammatory process, pulmonary hypertension, and decompensated chronic cardiac insufficiency (CCI).

Conclusions:

  • Elevated D-dimer is prevalent in CVD patients even without visible thromboses.
  • Female gender, advanced age, acute inflammation, pulmonary hypertension, and decompensated CCI are independent predictors of elevated D-dimer.
  • These findings aid in identifying at-risk CVD patients requiring closer monitoring for thrombotic events.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...